Which Tax Law Is Really Hurting Silicon Valley?
Silicon Valley is known for a lot of things. Some of the world’s greatest technological advances and ideas have come from companies located in the Silicon Valley. Likewise, some of the world’s most innovative and largest companies were born in Silicon Valley and still call it home today. Many people have found great success and riches in Silicon Valley, including many employees who helped build companies from the ground up.
There is a big problem, though, for many of these kinds of employees. There is a tax provision that is really hurting people who have worked for many years for start-ups or newer companies and have helped them become successful and valuable companies. However, when it coms time for many of these employees to leave their job or simply to cash out their stock options, they can’t really afford to pay the required cash outlay.
This problem should have been fixed when companies were allowed to give employees incentive stock options. However, in 1982, Congress changed that rule when it turned exercising an incentive stock option into a tax preference as part of the AMT. That meant any gain on the exercise of incentive stock was now taxed. This is very problematic for any employee in this boat, which is having a hard time exercising his or her options. In some cases, even if they can’t sell the stock, some employees end up owing tax on phantom income but they have no money to pay for it.
This tax provision is clearly causing problem for many people who have helped make Silicon Valley what it is today. And it’s a problem that the government should fix.
Armin Tahmasbi | Encapsulate
I’m a young entrepreneur and a Ph.D. candidate in Biomedical Engineering program at the University of Connecticut, working on “Drug Delivery Systems, Self-Assembled Nanoparticles & Microfluidic Devices”, in Storrs, CT, US. I’m working in Self-Assembled Functional Nanomaterials Laboratory, under the supervision of Prof. Mu-Ping Nieh on “Drug Delivery Systems for cancer therapy”. We’re developing a universal platform for encapsulating and smart delivery of a wide range of drug molecules and
Spencer Jones | Lineus Medical
Spencer worked for 3 years in direct patient care as a Certified Nursing Assistant, Licensed Practical Nurse, and as a Registered Nurse. Frustrated with the inefficiencies plaguing the healthcare system, he was determined to play a role in improving the delivery of healthcare. In 2014, Spencer won the annual ARK Challenge, an Arkansas based business accelerator. The product he developed was a dual lumen peripheral IV called the BVAD, which focuses on painless and uncontaminated blood draws.
Adeel Malik | CEO of Clearstep
While studying finance and neurobiology in undergrad, Adeel spent his time doing neuro-immunology research at the Johns Hopkins Hospital, contributing to several academic publications. After undergrad, Adeel was a strategy & analytics consultant with Accenture for several years where he worked with some of the largest institutions in healthcare across pharma, health tech, health systems, and retail clinics. Adeel’s skills in healthcare analytics, operations, sales, and his breadth of experience
Yael Katz | How BrainCheck is Democratizing Cognitive Health
Dr. Yael Katz is the co founder and CEO of Braincheck, a healthcare technology company focused on making cognitive health assessments more accessible. Prior to co founding Braincheck, Yael was VP of ecommerce at JW Player and a post doctoral research fellows at Princeton University. She received a Ph.D in in Biological Sciences focusing on Computational and Experimental Neuroscience from Northwestern University.Alan What brought you to co founding Braincheck? Yael If a person has a concern that